Biomedical industry bears fruit again in National Nanning Economic & Technological Development Area

National Nanning Economic & Technological Development Area Management Committee

PR97596

 

NANNING, China, Aug. 30, 2022 /Xinhua=KYODO JBN/--

 

Recently, the lung CT image-aided diagnosis software developed by Guangxi

Yizhun Intelligent Technology Co., Ltd. ("Yizhun") in National Nanning Economic

& Technological Development Area ("Area") has been granted the registration

certificate of class III medical devices (GXZZ20223210687).

 

Nanning's investment promotion departments at all levels aim at creating

biomedical industry clusters through high starting point planning and

attraction of targeted investments, according to National Nanning Economic &

Technological Development Area Management Committee. In the Area, the

biomedical industry, involving the fields of production, inspection & testing,

sales and distribution, continually expands in industrial scale and gradually

improves in industrial chain. The approved "lung CT image-aided diagnosis

software" is the first software in Guangxi province and the country's eighth

one with the registration certificate of class III AI medical devices and

software, and the sixth in Guangxi province and the second in Nanning city to

have received the certificate. This is another achievement of the city's

continuous optimization of services for moved-in enterprises and solid efforts

in building up the biopharmaceutical industry.

 

In terms of precise investments, the Area has compiled a panorama of

biopharmaceutical industry chain, positively brought in investments in the

industry chain and industry clusters and introduced a batch of key projects

such as Hainan Huluwa Pharmaceutical, Guangdong Yili Pharmaceutical, Yida

Xiansheng, Sinopharm Group and Guangxi LiuYao Group, forming an industrial

development pattern with biopharmaceuticals, traditional Chinese medicine,

health care products, medical devices and modern pharmaceutical logistics as

main fields. According to information, the Area is the major ground to develop

the biopharmaceutical industry in the city, and there are currently 625

biopharmaceutical enterprises in the Area.

 

Source: National Nanning Economic & Technological Development Area Management

Committee

 

Image Attachments Links:

 

   Link: http://asianetnews.net/view-attachment?attach-id=428269

 

   Caption: Production workshop of Nanning Neptunus Health Industrial Park

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中